News
VRAY
--
0.00%
--
ViewRay Announces Conference Call for First Quarter 2021 Financial Results to be Held After Market on May 6, 2021
, /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) announced today details relating to the release of its first quarter 2021 financial results.
PR Newswire - PRF · 1d ago
Radiotherapy Market Estimated to Experience a Hike in Growth by 2025 | Says Kenneth Research
Apr 13, 2021 (AmericaNewsHour) -- Kenneth Research recently added a report on 'Radiotherapy Market’ in its database of market research reports which provides...
AmericaNewsHour · 04/13 05:43
Radiotherapy Market Worth USD 6.8 billion by 2023 – Growth Factors, Top Players and Competitive Regional Growth Analysis
Apr 08, 2021 (AB Digital via COMTEX) -- This report aims to provide detailed insights into the global radiotherapy market. It provides valuable information...
ABNewswire · 04/08 22:35
AtriCure Names B. Kristine Johnson Board Chair
AtriCure, Inc. (NASDAQ:ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that B. Kristine (Kris) Johnson has been named Board Chair. In
Benzinga · 04/08 12:12
Radiotherapy Market Analysis By Global Industry Share, Merger, Acquisition, Size Estimation, New Investment Opportunities, Statistics, Overview, and Forecast till 2027
Mar 30, 2021 (Market Insight Reports) -- The rise in the incidences of cancer, improved technological advances, new product launches, and strategic...
Market Insight Reports · 03/30 15:58
ViewRay initiated buy at BTIG on management remarks
ViewRay ([[VRAY]] +7.0%) is on the rise today after BTIG analyst Marie Thibault initiated the coverage on the stock with a buy recommendation citing among other things the upbeat management
Seekingalpha · 03/26 15:41
Thinking about buying stock in Oncolytics Biotech, Boxlight Corp, IVERIC bio, Telos Corp, or Viewray?
, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ONCY, BOXL, ISEE, TLS, and VRAY.
PR Newswire - PRF · 03/26 13:31
Aspira extends gains as analysts weigh in; Flexion to benefit from Pfizer’s failure in osteoarthritis drug and more in today’s analyst action
Aspira Women's Health (AWH) has extended the post-market gains with a ~12.2% rise in the pre-market as analysts weigh in on its new agreement to develop an early detection test for ovarian cancer.“We
Seekingalpha · 03/26 12:20
DJ ViewRay Price Target Announced at $7.00/Share by BTIG
Dow Jones · 03/26 12:20
DJ ViewRay Raised to Buy From Neutral by BTIG
Dow Jones · 03/26 12:20
Global Radiotherapy Market Trends, Forecast and Competitive Analysis Report 2020 – Emergen Research
Mar 25, 2021 (Market Insight Reports) -- Market Size - USD 5.82 billion in 2019, Market Growth – CAGR of 3.4%, Market Trends - Favorable government...
Market Insight Reports · 03/25 15:11
Global Radiation Therapy Market Size, Share To Witness Considerable Expansion During 2020-2025
Mar 18, 2021 (Market Insight Reports) -- Selbyville, Delaware. The report Radiation Therapy Market Size and Analysis maintains enhanced dynamics and is...
Market Insight Reports · 03/18 13:59
If You Had Bought ViewRay (NASDAQ:VRAY) Stock A Year Ago, You Could Pocket A 224% Gain Today
When you buy shares in a company, there is always a risk that the price drops to zero. But if you pick the right...
Simply Wall St. · 03/16 13:13
Radiotherapy Market Size to Reach USD 7.65 Billion by 2027; Industry Compound Annual Growth Rate of 3.4% | Market Trend – Favorable government investment.
Market Insight Reports · 03/16 07:55
ViewRay Chief Operating Officer to step down
ViewRay (VRAY) announced that Shahriar Matin, Chief Operating Officer, will leave the company effective March 31, 2021.Matin was named Chief Executive Officer designate of Cordis in its recently announced divestiture from
Seekingalpha · 03/15 13:13
ViewRay: COO Shahriar Matin to Leave Co Effective March 31 >VRAY
ViewRay: COO Shahriar Matin to Leave Co Effective March 31 >VRAY
Dow Jones · 03/15 13:02
Press Release: ViewRay Announces Departure of Chief Operating Officer
Dow Jones · 03/15 13:00
ViewRay Announces Departure Of Chief Operating Officer >VRAY
ViewRay Announces Departure Of Chief Operating Officer >VRAY
Dow Jones · 03/15 13:00
NXPI, TPIC, EOLS and UBX among after-hours movers
Gainers: [[RUBY]] +16.8%. [[SALM]] +7.5%. [[NXPI]] +5%. [[CHMA]] +3.5%. [[UBX]] +2.7%.Losers: [[CLPS]] -4.2%. [[AMTX]] -3.9%. [[VRAY]] -3.2%. [[TPIC]] -2.8%. [[EOLS]] -2.5%.
Seekingalpha · 03/12 22:56
Radiosurgery and Radiotherapy Robotics Market Share 2021 CAGR Status, Analysis, Growth Rate, Industry Overview, Top Key Players, Market Size and Forecast 2025
The Express Wire · 03/09 08:46
Webull provides a variety of real-time VRAY stock news. You can receive the latest news about ViewRay through multiple platforms. This information may help you make smarter investment decisions.
About VRAY
ViewRay Inc. designs, manufactures and markets the ViewRay MRIdian. The MRIdian is a system that integrates high quality radiation therapy with simultaneous magnetic resonance imaging (MRI). It provides two generations of the MRIdian: the first generation MRIdian with Cobalt-60 based radiation beams and the second generation MRIdian Linac, with linear accelerator (linac) based radiation beams. The MRIdian combines MRI and external-beam radiation therapy to simultaneously image and treat cancer patients. MRIdian also records the level of radiation dose that the treatment area has received. MRIdian system is comprised of three components: the MRI system, the radiation delivery system and an integrated treatment planning and delivery software. The MRI system is the component of MRIdian that captures soft tissue images of the patient’s body. Its MRI system captures and displays live images in one plane, four times per second or in three planes, two times per second.